LCRF – Boehringer Ingelheim Early Investigator Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer
Funding Amount
Varies
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Early career scientists, physicians, students, and fellows working on HER2-driven lung cancer research
Overview
Funder: Lung Cancer Research Foundation (LCRF) and Boehringer Ingelheim
Geographic Scope: International (scientists around the world)
Focus Areas: Innovative treatment approaches for HER2-driven lung cancer
Description
Annual early investigator award supporting innovative research on treatment strategies for HER2-driven lung cancer. Recipients are selected from hundreds of applicants.
Eligibility
Open to early career scientists, physicians, students, and fellows working on HER2-driven lung cancer research.
Contact
- Phone: (212) 588-1580
- Email: info@LCRF.org
- Mailing Address: PO Box 780990, Philadelphia, PA 19178-0990
What Lung Cancer Research Foundation actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 23
- Total given
- $2.6M
- Median grant
- $30K
- Range
- $6,405–$801K
- By dollars: Massachusetts 34%, New York 31%, Michigan 9%. Top recipient cities: Boston, MA; New York, NY; Ann Arbor, MI.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
Dana-Farber Cancer Institute Inc · Boston, MA
Research
$801K
American Society of the Italian Legions of Merit · New York, NY
Research
$320K
Alumni Association of the University of Michigan · Ann Arbor, MI
Research
$231K
UCLA · Los Angeles, CA
Research
$199K
Memorial Sloan Kettering Cancer Center · New York, NY
Research
$176K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
LCRF | Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations
Lung Cancer Research Foundation
Amount
Varies
Deadline
Deadline not published
LCRF Leading Edge Research Grant Program
Lung Cancer Research Foundation
Amount
Varies
Deadline
Deadline not published
LCRF Minority Career Development Award (CDA) in Lung Cancer
Lung Cancer Research Foundation
Amount
Varies
Deadline
Deadline not published
LCRF Research Grant on Prevention and Early Detection in Lung Cancer
Lung Cancer Research Foundation
Amount
Varies
Deadline
Deadline not published
LCRF Research Grants on Overcoming Resistance in Lung Cancer
Lung Cancer Research Foundation
Amount
Up to US $150,000
Deadline
Deadline not published
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
Ready to apply for LCRF – Boehringer Ingelheim Early Investigator Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found LCRF – Boehringer Ingelheim Early Investigator Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer. Now let's win it.